Sage, a senior care startup based in Chelsea, has raised $65 million to expand its AI-powered platform to help senior living centers predict resident safety concerns and support caregivers.

Care technology company Sage has raised $65 million in a Series C funding round led by Goldman Sachs Alternatives. Meanwhile, Carefam has raised $14.5 ...

Sage Therapeutics Inc.’s stock SAGE fell 2.4% Wednesday, headed for a fresh all-time low after the company said it would cease developing a treatment for cognitive impairment associated with ...

The stock suffered a double whammy of news that drove it lower. First, last Friday, after the markets closed, Sage and Biogen announced that their therapy Zurzuvae (zuranolone) had been approved by ...

TD Cowen analyst Ritu Baral maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $6.43. Baral covers ...